Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
StanwixForbes LLC
Kamineni Life Sciences Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex, 18 to 75 years of age (both inclusive). 2. Patients with clinical symptoms of SARS-CoV-2. 3. Willing to come for follow â??up visit. 4. Able to give written informed consent
Exclusion criteria
Exclusion criteria: 1. Volunteers who are in ICU or unconscious or unable to give breath samples. 2. History of having received or participated in any other similar clinical trial in the last 24 hrs or currently ongoing. 3. Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. % difference in the positivity or negativity of the COVID-19 results between invasive and non-invasive sample testing/ diagnosis. 2. % difference in the viral load of the COVID-19 samples between invasive and non-invasive breath sample testing/ diagnosis using RT-PCR method. Timepoint: Day 0 and Day 7 or Date of discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Volunteersâ?? feedback on the non-invasive breath sampling device compared to the invasive testing method using a feedback questionnaireTimepoint: Day 0 and Day 7 or Date of discharge | — |
Countries
India
Contacts
Public ContactAndrew Ganesh
StanwixForbes LLC
Outcome results
None listed